TGF-DES vs IGF-1 DES: China Supplier Naming Guide

Do not expand DES by assumption

Ask the supplier to provide the complete product name, controlled abbreviation, amino-acid sequence or construct boundaries, termini, modifications, species reference, production route, form, target quality criteria, nominal content and RUO status. Record TGF-DES, IGF-1 DES, des(1-3) IGF-1 and any internal DES code as separate terms until evidence establishes their meaning. A search result, catalog category, CAS field or neighboring IGF product cannot authorize an automatic synonym mapping.

Separate TGF-family and IGF-family identities

TGF and IGF labels refer to different growth-factor families, while des(1-3) naming usually describes a defined N-terminal truncation in an IGF-1 context. The buyer should compare the supplier's full sequence, residue numbering, length, expected mass and source reference against the requested material. If a TGF-DES listing actually means IGF-1 DES, the supplier should issue corrected controlled documents; if it denotes another construct, that construct requires its own specification. Never resolve the difference from a product photograph or sales message.

Verify truncation boundaries and molecular target

Where an IGF-1 DES material is requested, state the exact truncation boundaries and remaining construct rather than relying on DES alone. For any TGF-related material, require its own unambiguous construct definition. Compare expected and observed molecular information, sequence length, terminal state and tag or carrier status where applicable. A molecular mass mismatch is a substantive identity exception. A matching nominal strength or white lyophilized appearance provides no evidence that two differently named growth-factor materials are the same.

Use analytical files within their proper scope

Request complete batch-linked chromatographic, electrophoretic or mass-spectrometric evidence appropriate to the exact material and production route. Review the sample ID, expected profile, complete data, method reference, dates, result and authorization and ask how the sample connects to finished units. HPLC area purity cannot establish the intended family, truncation boundary, residue order or exact content. MS can support molecular identity but does not alone prove purity, sequence order, formulation or finished-vial quantity.

Create a naming gate before quote and label approval

Require the quotation, purchase order, specification, COA, analytical files, vial label, invoice and packing list to use one full controlled name plus a consistent SKU. Block generic DES labels on mixed orders. Map the legal seller, manufacturer, laboratory, filler and release authority and confirm who owns the master identity record. Approve the 2mg quantity only after the exact target and quantitative basis are clear. Quarantine any family, sequence, strength, SKU or certificate conflict until a traceable correction is completed.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• TGF-DES 2mg
• IGF-1 LR3 1mg
• IGF-1 LR3 Supplier Guide
• Custom Peptide RFQ Checklist

Frequently asked questions